BCRX
BioCryst Pharmaceuticals Inc
NASDAQ: BCRX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$8.99
+1.47% today
Updated 2026-04-29
Market cap
$2.28B
P/E ratio
7.43
P/S ratio
2.61x
EPS (TTM)
$1.21
Dividend yield
—
52W range
$6 – $11
Volume
5.5M
BioCryst Pharmaceuticals Inc (BCRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $99.25M | $68.49M | $142.72M | $84.69M | $142.19M | $110.57M | $82.21M | $57.44M | $48.87M | $136.87M | $124.56M | $89.85M | $178.26M | $146.84M | $175.28M | $334.71M | $588.15M | $550.00M | $516.96M | $490.42M |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $81.10M | $45.79M | $91.70M | $75.02M | $111.02M | $97.69M | $63.56M | $41.98M | $42.12M | $89.34M | $65.99M | $66.99M | $125.39M | $114.35M | $164.34M | $323.80M | $566.14M | $516.50M | $495.97M | $421.97M |
| Total liabilities | $40.81M | $47.33M | $77.81M | $38.27M | $55.92M | $43.94M | $67.40M | $57.89M | $49.99M | $61.24M | $76.83M | $88.27M | $94.49M | $97.61M | $137.03M | $353.98M | $695.14M | $844.60M | $972.49M | $966.35M |
| Current liabilities | $11.38M | $10.73M | $28.12M | $17.11M | $37.25M | $27.82M | $12.28M | $17.22M | $15.26M | $57.69M | $64.45M | $54.36M | $74.84M | $69.48M | $92.33M | $105.65M | $103.72M | $105.51M | $149.99M | $160.38M |
| Long-term debt | — | — | — | — | — | — | $30.00M | $30.00M | $30.00M | $0.00 | $2.38M | $22.78M | $16.75M | $25.37M | $41.29M | $119.73M | $585.46M | $733.28M | $811.26M | $795.92M |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-151.86M | $-195.48M | $-224.54M | $-249.27M | $-262.72M | $-295.45M | $-353.52M | $-392.60M | $-422.71M | $-467.90M | $-510.92M | $-566.06M | $-631.84M | $-731.97M | $-840.63M | $-1.02B | $-1.21B | $-1.45B | $-1.68B | $-1.77B |
| Accounts receivable | $30.00M | $4.56M | $39.13M | $11.98M | $33.72M | $30.23M | $7.57M | $4.56M | $2.12M | $9.49M | $6.24M | $8.77M | $6.12M | $4.29M | $22.15M | $8.65M | $29.41M | $50.60M | $56.95M | $79.07M |
| Inventory | $-51.94B | $-8.33B | $-41.01B | $-13.49B | $6.28M | $898076.00 | $263000.00 | $-431000.00 | $-2.36M | $683000.00 | $1.61M | $500000.00 | $-37.80M | $1.65M | $1.55M | $7.04M | $15.79M | $27.53M | $28.68M | $8.09M |
| Goodwill | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |